Miller D D, Osei-Gyimah P, Bardin J, Feller D R
J Med Chem. 1975 May;18(5):454-7. doi: 10.1021/jm00239a002.
The synthesis of N-(3',4',5'-trimethoxyphenylethyl)-3,4-dihydroxyphenylethylamine (2) and 1-(3,4,5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (1) is presented. Comparative pharmacological effects of the optical isomers of 1 and compound 2 are reported in guinea pig atria, rat adipose tissue, guinea pig trachea, and guinea pig aortic strip preparations. In the beta-adrenoreceptor preparations, (-)-1 was shown to be more potent than (+)-1 or 2. Racemic 1 and 2 were shown to have equal alpha-antagonist properties in the inhibition of norepinephrine-induced contractions of guinea pig aorta.
本文介绍了N-(3',4',5'-三甲氧基苯乙基)-3,4-二羟基苯乙胺(2)和1-(3,4,5-三甲氧基苄基)-6,7-二羟基-1,2,3,4-四氢异喹啉(1)的合成方法。报道了1和化合物2的光学异构体在豚鼠心房、大鼠脂肪组织、豚鼠气管和豚鼠主动脉条制剂中的比较药理作用。在β-肾上腺素能受体制剂中,(-)-1比(+)-1或2更有效。消旋的1和2在抑制去甲肾上腺素引起的豚鼠主动脉收缩方面显示出相同的α-拮抗剂特性。